Our in vitro and in vivo study using TNFR2 antagonistic antibody demonstrated that targeting TNFR2 exerts an antitumor effect against breast cancer cell proliferation and induces tumor cell apoptosis. Here, TNFRSF1B is linked to breast carcinoma.